Alsius Corporation (Alsius) has reported preliminary results for the fourth quarter and year ended December 31, 2008. For the year, Alsius expects revenues to be about $12.4 million, an annual record, compared with $9.1 million for the full year of 2007. For the fourth quarter, Alsius expects revenues improved more than 40% to an expected quarterly record of about $3.8 million, compared with $2.7 million in the fourth quarter of 2007.
In addition to strong revenue, the number of systems and catheters Alsius sold in the United States during the fourth quarter of 2008 also marked a new high. Sales in Europe increased solidly from the previous year, as well.
“The achievement of record revenue in each of the last three quarters, especially in today’s tough capital spending environment, is a testament to two factors: quality products addressing a significant need and adept execution,” said Bill Worthen, president and chief executive officer of Alsius. “Expanding awareness among healthcare providers of our IVTM solutions is serving to increase U.S. demand. We are seeing temperature management increasingly incorporated into treatment protocols, as is evidenced by New York City’s recent requirement that therapeutic cooling must be available to cardiac arrest victims transported in city ambulances. This growing recognition coupled with the hard work of the Alsius team served to deliver record results. In addition, we were able to build our pipeline of leads during the quarter, which further confirms our belief in the opportunity and we expect will lead to additional success in 2009.”